The IMID Forum
The Immune-Mediated Inflammatory Disease Forum
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
Notable Guests
Episodes (421)
Discussing Rheumatology: Patient Reported Outcomes
The IMID Forum
Discussing Rheumatology: SELECT-PsA 2 and DMARDs in COVID-19
The IMID Forum
Rheumatology Author Professor Mease: Upadacitinib
The IMID Forum
Rheumatology Authors Jeffrey Sparks and Zachary Wallace
The IMID Forum
Rheumatology Author Professor Francesco Ciccia: JAKis and Pain
The IMID Forum
Discussing Rheumatology: 2021 EULAR Highlights
The IMID Forum
Rheumatology Author Professor Stanley Cohen: Radiographic Progression
The IMID Forum
Insights at EULAR 2021: Day 4 Highlights
The IMID Forum
Insights at EULAR 2021: Day 3 Highlights
The IMID Forum
Insights at EULAR 2021: Day 2 Highlights
The IMID Forum
Insights at EULAR 2021: Day 1 Highlights
The IMID Forum
Insights at EULAR 2021: Preview
The IMID Forum
Discussing Rheumatology: PsA and Radiographic Progression
The IMID Forum
Rheumatology Author Professor Yoshiya Tanaka: Filgotinib
The IMID Forum
Rheumatology Author Dr Rishi Desai: VTE
The IMID Forum
Discussing Rheumatology: JAKi and VTE
The IMID Forum
Rheumatology Author Dr Ben Nowell: ArthritisPower
The IMID Forum
Discussing Rheumatology: Bone and PRO
The IMID Forum
Rheumatology Author Professor Paul Emery: Baricitinib
The IMID Forum
Forum LIVE: Managing Patients During COVID
The IMID Forum
Rheumatology Author Professor Lee Simon: Pain in RA
The IMID Forum
Rheumatology Author Professor Tsutomu Takeuchi: Upadacitinib
The IMID Forum
Rheumatology Author Prof René Westhovens: Filgotinib
The IMID Forum
Discussing Rheumatology: February 2021 Podcast
The IMID Forum
Perspectives in Inflammation - Dr Grace Wright
The IMID Forum
Rheumatology Author Prof György Nagy: EULAR
The IMID Forum
Rheumatology Author Prof Philip Mease: Upadacitinib in PsA
The IMID Forum
Discussing Rheumatology: JAKi and TNFi
The IMID Forum
Perspectives In Inflammation - Professor Weinblatt
The IMID Forum
Rheumatology Author Prof Josef Smolen: Barcitinib
The IMID Forum
Rheumatology Author Roy Fleischmann: Switching Between UPA and ADA
The IMID Forum
Rheumatology Author Dr Kerschbaumer: JAKinibs
The IMID Forum
Rheumatology Author Prof Kevin Winthrop: Tofacitinib
The IMID Forum
Discussing Rheumatology: JAK Inhibitors
The IMID Forum
Perspectives in Inflammation - Professor Emery
The IMID Forum
Insights at ACR 2020: Highlights from ACR 2020
The IMID Forum
Rheumatology Author Prof Stanley Cohen: Upadacitinib
The IMID Forum
Discussing Rheumatology: Upadacitinib Safety
The IMID Forum
Insights at ACR 2020: Efficacy And Safety Of JAK Inhibitors
The IMID Forum
Insights at ACR 2020: New Developments in Cytokine Signalling
The IMID Forum
Insights at ACR 2020: Bone And Patient Outcomes With RA
The IMID Forum
Insights at ACR 2020: Vaccinations and JAK Inhibitors
The IMID Forum
Rheumatology Author Gustavo Citera: Interstitial Lung Disease
The IMID Forum
Insights at ACR 2020: Day 4 Beyond RA Highlights
The IMID Forum
Insights at ACR 2020: Day 4 RA Highlights
The IMID Forum
Insights at ACR 2020: Day 3 RA Highlights
The IMID Forum
Insights at ACR 2020: Day 3 Beyond RA Highlights
The IMID Forum
Insights at ACR 2020: Day 2 RA Highlights
The IMID Forum
Insights at ACR 2020: Day 2 Beyond RA Highlights
The IMID Forum
Insights at ACR 2020: Day 1 RA Highlights
The IMID Forum